Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
Clinical trial NCT06005532 · UNKNOWN
Trial details
- NCT number
- NCT06005532
- Sponsor
- Mabscale, LLC
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-02
- Primary completion
- 2025-03-01
- Enrollment
- 494
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.